Introduction
Congenital adrenal hyperplasia (CAH)' is a group of inborn errors of steroid hormone synthesis. Distinct autosomal recessive forms of CAH have been described for each step in the conversion of cholesterol to the principal secretory products of 1 . Abbreviations used in this paper: CAH, congenital adrenal hyperplasia; hCG, gonadotropin; PCR, polymerase chain reaction; PRA, plasma renin activity. the adrenals (for reviews see references 1, 2) . Because the enzymes responsible for adrenal steroidogenesis also participate in gonadal steroidogenesis, many forms of CAH also affect gonadal sex steroid synthesis.
The most severe form of CAH is congenital lipoid adrenal hyperplasia (lipoid CAH). This disorder is characterized by an absence of significant circulating or urinary concentrations of all steroids, high basal concentrations of adrenocorticotropin (ACTH) and plasma renin activity (PRA), absent steroidal response to long-term treatment with high doses of ACTH or human chorionic gonadotropin (hCG), and grossly enlarged adrenals laden with cholesterol and cholesterol esters (3) (4) (5) (6) . These findings have suggested that the lesion is in the first step in steroidogenesis, the conversion of cholesterol to pregnenolone. Enzymologic studies (6) (7) (8) (9) confirmed that adrenal and gonadal tissue from these patients failed to convert cholesterol to pregnenolone, consistent with the notion that the lesion is in the enzyme converting cholesterol to pregnenolone.
The conversion of cholesterol to pregnenolone is mediated by a single mitochondrial enzyme, cytochrome P450scc (EC 1.14.15.67) (for reviews see references [10] [11] [12] . P450scc functions as the terminal oxidase in an electron transport chain. Electrons from NADPH are donated to a membranebound flavoprotein, termed adrenodoxin reductase, then passed to a soluble iron/sulfur protein, termed adrenodoxin, and then passed to P450scc. Congenital lipoid adrenal hyperplasia might conceivably be caused by a genetic lesion in any of the three components ofthe side-chain cleavage system. In one autopsied patient, P450scc protein was undetectable (9) , thus implying that the lesion was in P450scc. A lesion in adrenodoxin reductase or adrenodoxin appears most unlikely. Adrenodoxin and adrenodoxin reductase have been isolated from various tissues with properties indistinguishable from the adrenal proteins (for references see 13) . These proteins thus interact with many other mitochondrial cytochrome P450 enzymes, such as hepatic bile acid 26-hydroxylase/vitamin D 25-hydroxylase, (14, 15) or renal vitamin D l-hydroxylase (16) . There is only one human gene for adrenodoxin reductase, located on chromosome 17q24-q25 (17) (18) (19) that is expressed in all human tissues examined, (20) hence a disorder in this gene should have effects extending far beyond the steroidogenic tissues. Similarly, there are one (21) or two (22) nearly identical genes for adrenodoxin closely linked on chromosome 1 1q22 (19, 22, 23) that encode identical proteins (23) ; this mRNA is also found in all tissues examined (24) . Thus, it has generally been agreed that congenital lipoid adrenal hyperplasia represents a genetic defect in the human P450scc gene (1, 25) .
To date, only one study has directly examined the P450scc genes in patients with lipoid CAH. Matteson et al. (26) used oligonucleotide probes and a partial-length P450scc cDNA to P450scc gene (27) on chromosome 15q23-q24 (19) indicates that the oligonucleotides and partial-length cDNA used in that study could have missed deletions at the 5' end of the gene. We now report a new case oflipoid CAH, and the sequencing of the cDNA and the exons for this patient's P450scc gene and of the gene from our previously reported patient (6) . The normal P450scc gene sequences in these two patients and the grossly normal RNA blotting studies of all of the components of the cholesterol side chain cleavage system and known components of the cholesterol transport system indicate that new models of this disorder must be considered, possibly searching for other factors in the delivery ofcholesterol to the mitochondria.
Case reports Case 1. A 3,320-g newborn Korean infant without known consanguinity was referred to one ofus (PS) because ofa 6.5-yr-old female sibling had previously been diagnosed as having congenital adrenal hyperplasia due to 33- Table I . Other studies included normal thyroid function studies and a plasma ACTH of 585 pg/ml at 40 d of age (normal . 100 pg/ml).
At 6.5 mo ofage a gonadectomy was performed. The internal reproductive structures included undescended testes each measuring 9 x 5 x 5 mm, and no Millerian structures (fallopian tubes, uterus, cervix) consistent with testicular synthesis of Mullerian inhibitory factor but not of steroids (28, 29) . The histologic examination of the gonadal tissue showed normal testes bilaterally.
Recent hormonal reevaluation of the 7-yr-old 46 XX sibling showed low but detectable concentrations of adrenal steroids with no response to 0.25 mg ofintravenous ACTH (1-24) (Cortrosyn; Organon Diagnostics, West Orange, NJ) at a time when steroidal replacement therapy was discontinued for 36 h (Table II) . Thus, both siblings appear to have the same, presumably autosomal recessive defect in the synthesis of all steroid hormones.
Case2. The clinical, laboratory, radiographic, andbiochemical findings in case 2 have been reported in detail previously (6) . Her DNA was also included in the study ofMatteson et al. (26) (27) . Where possible, these primers were 10-20 bases from intron/exon junctions to facilitate sequencing these junctions; however, for primers 3'sccl and 5'scc6, the available sequence data for the introns did not permit this. The sequences of each pair of primers and their distances from the intron/ exon junctions are shown in Table III. PCR products were extracted with phenol/chloroform and purified by passing through a Centricon-100 filter (Amicon, Beverley, MA The sizes ofthe resulting PCR products are listed in Table III . Oligonucleotide pairs 5'sccl and 3'sccl through 5'scc7 and 3'scc7, respectively, amplified exons 1-7 as small fragments of 135-335 bp. These were cloned and completely sequenced on each strand from single reactions. Oligonucleotide pair 5'scc8 and 3'scc9 spanned exons 8 and 9, and intron 8, resulting in a fragment of-850 bp. This larger fragment was cleaved into two smaller fragments, each containing one exon, with restriction endonuclease Acc I. These two smaller fragments were then subcloned and sequenced on each strand. For both patients, two completely separate enzymatic amplifications were made with all eight pairs ofoligonucleotides and the products ofall 16 PCR reactions were cloned and completely sequenced on both strands. 
Results
Clinical studies. The diagnosis of a severe salt-wasting form of congenital adrenal hyperplasia in a sibling resulted in early referral and evaluation of patient No. 1. The patient's lack of clinically significant hyponatremia and hyperkalemia at 2 d of life followed by development ofsevere hyponatremia, hyperkalemia, acidosis, and shock by 7-10 d is typical of all forms of salt wasting congenital adrenal hyperplasia (1, 2). The minimal basal concentrations of the A5 steroids (pregnenolone, 170H- pregnenolone, and dehydroepiandrosterone) and their failure to rise in response to tropic hormonal stimulation rule out the diagnosis of 3,3 hydroxysteroid dehydrogenase deficiency that had been made (incorrectly) in the sibling. The elevated basal concentration of ACTH and the minimal concentrations of all adrenal and gonadal steroids and their unresponsiveness to stimulation with ACTH and hCG, respectively, establish the diagnosis of congenital lipoid adrenal hyperplasia. The measurement of steroid values that are greater than zero does not necessarily mean a "partial enzyme deficiency." Some of the steroids measured at 2-10 d of age represent residual maternal steroids (6) , as shown by the lower values, even after tropic stimulation, at 3-4 wk of age (Table I) . Furthermore, extraadrenal and extragonadal steroidogenesis do occur, especially in the fetus (39, 40) ; however, this peripheral steroidogenesis is mediated by enzymes other than those found in the adrenals and gonad (41) (42) (43) . Thus, the hormonal data unambiguously establish a defect in the synthesis of pregnenolone and all other steroid hormones. This has, to date, been interpreted as a lesion in P450scc (1, 6, 9, 12, 25) . Similarly, the studies in the 7-yr, 10-mo-old sister suggest the presence of low concentrations of some adrenal steroids while other steroids, such as progesterone and androstenedione, were undetectable. However, these minimal steroid concentrations did not rise in response to ACTH (Table II) . (27) (Fig. 1) Fig. 3 A, a band ofP450scc mRNA was readily detectable in the RNA from the patient's testis. This band is identified as P450scc mRNA by its comigration at the expected 2.0-kb size with P450scc mRNA from a control RNA sample (from the testis of a 20-wk gestation fetus) and by its intense hybridization under highly stringent hybridization and washing conditions. Thus the promoter of the P450scc gene in patient No. 1 was able to direct the synthesis of P450scc mRNA, and, as shown by the sequencing studies, that P450scc mRNA was completely normal.
As it has been deduced, but not experimentally proven, that a lesion in adrenodoxin reductase or adrenodoxin would have more devastating and widely ranging manifestations than those seen in lipoid CAH, we then examined these mRNAs in patient
No. 1. We removed the P450scc probe from the northern blot in Fig. 3 A by boiling (and repeating the autoradiography to show that no residual 32P remained on the membrane), then reprobed the blot with 32P-labeled cDNA for adrenodoxin (Fig.  3 B) . This procedure was then repeated and the blot reprobed for adrenodoxin reductase (Fig. 3 C) . The mRNA from the patient's testis had mRNAs for adrenodoxin and adrenodoxin reductase, as expected. Each of these mRNAs comigrated with the corresponding mRNA in the control tissue, and each mRNA hybridized under highly stringent conditions, indicating the presence of normal-sized mRNA. Because the control was tissue from a 20-wk fetus, quantitative comparisons ofthe abundance of each mRNA in the patient's tissue and the control should not be made. While the hybridization pattern in Fig. 3 (Fig. 1) , and can be transcribed into stable mRNA of normal size (Fig. 3) 
